Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenhuang Granule (SHG) is a multi-component Traditional Chinese Medicine (TCM) formulation. It is composed of six ingredients: Radix Ginseng (Renshen), Rhei Radix et Rhizoma (Dahuang), Radix Aconiti Lateralis Preparata (Fuzi), Caulis Sargentodoxae (Daxueteng), Herba Taraxaci (Pugongying), and Hirudo (Shuizhi). [1] Based on TCM principles, the formulation is designed to strengthen vital energy, clear heat, detoxify, and promote qi and blood circulation. [2, 8] It has been investigated in clinical trials for several conditions, including postoperative ileus, sepsis, and severe COVID-19. [1, 2, 3] Network pharmacology and molecular docking studies suggest that its numerous active constituents act on multiple targets and biological pathways to exert its effects, which may include inhibiting viral invasion and modulating cytokine storms. [1, 4] The product has been manufactured by companies including Beijing Tcmages Pharmaceutical Co. Ltd and Tianjin Hongri Pharmaceutical Co., LTD. [1, 3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenhuang granule.